Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2026-05-01 16:37:24 ET · period of report 2026-04-30 · accession 0000897069-26-001006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 16:37 | 2026-04-30 | PCSA | Ng George K | CEO, Dir | P - Purchase | $2.69 | +2,034 | 6,013 | +51% | +$5,471 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-30 | P | A | 2,034 | $2.69 | 6,013 | D | — | — |